MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Edwards Lifesciences Corp

Затворен

СекторЗдравеопазване

72.08 0.45

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

70.64

Максимум

72.34

Ключови измерители

By Trading Economics

Приходи

-2.7B

346M

Продажби

31M

1.4B

P/E

Средно за сектора

30.714

63.778

EPS

0.59

Марж на печалбата

24.989

Служители

15,800

EBITDA

55M

484M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+7.89% upside

Дивиденти

By Dow Jones

Следващи печалби

23.04.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-1.1B

42B

Предишно отваряне

71.63

Предишно затваряне

72.08

Настроения в новините

By Acuity

22%

78%

55 / 386 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bullish Evidence

Edwards Lifesciences Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

15.07.2024 г., 13:57 ч. UTC

Придобивния, сливания и поглъщания

Edwards Lifesciences to Buy Innovalve for $300 Million

25.10.2024 г., 09:10 ч. UTC

Печалби

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

25.10.2024 г., 08:35 ч. UTC

Печалби

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

3.09.2024 г., 20:38 ч. UTC

Придобивния, сливания и поглъщания

Edwards Lifesciences: After Recent Accelerated Repurchase Agreement and August Buybacks Via 10b5-1 Agreement and Open Market Repurchases, Company Has $1.4B in Remaining Authorization

3.09.2024 г., 20:37 ч. UTC

Придобивния, сливания и поглъщания

Edwards Lifesciences Completes Sale of Critical Care Group to Becton Dickinson for $4.2B

3.09.2024 г., 20:36 ч. UTC

Придобивния, сливания и поглъщания

Edwards Lifesciences Authorizes $1.5B of Additional Share Repurchases

25.07.2024 г., 09:02 ч. UTC

Печалби
Горещи акции

Stocks to Watch Thursday: Ford, IBM, Chipotle, American Airlines -- WSJ

25.07.2024 г., 08:40 ч. UTC

Топ новини

These Stocks Are Moving the Most Today: Ford, Tesla, Alphabet, Nvidia, Super Micro, IBM, ServiceNow, Chipotle, and More -- Barrons.com

24.07.2024 г., 20:17 ч. UTC

Печалби

Edwards Lifesciences: Expects 2024 Edwards Sales Growth of 8% to 10% >EW

24.07.2024 г., 20:15 ч. UTC

Придобивния, сливания и поглъщания

Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix

24.07.2024 г., 20:15 ч. UTC

Печалби

Edwards Lifesciences 2Q Sales $1.39B >EW

24.07.2024 г., 20:15 ч. UTC

Печалби

Edwards Lifesciences 2Q Net $366.3M >EW

24.07.2024 г., 20:15 ч. UTC

Печалби

Edwards Lifesciences 2Q Adj EPS 70c >EW

24.07.2024 г., 20:15 ч. UTC

Печалби

Edwards Lifesciences 2Q EPS 61c >EW

15.07.2024 г., 13:42 ч. UTC

Придобивния, сливания и поглъщания

Edwards Lifesciences to Buy Innovalve for $300M

15.07.2024 г., 13:01 ч. UTC

Придобивния, сливания и поглъщания

Edwards Lifesciences: SAPIEN M3 Remains on Track to Become First Approved Transfemoral TMVR System in Europe by End of 2025 >EW

15.07.2024 г., 13:01 ч. UTC

Придобивния, сливания и поглъщания

Edwards Lifesciences: Acquisition Enhances TMVR Technologies to Address Large Unmet Structural Heart Patient Needs >EW

15.07.2024 г., 13:00 ч. UTC

Придобивния, сливания и поглъщания

Edwards Lifesciences to Acquire Innovalve Bio Medical Ltd., Early-Stage Transcatheter Mitral Valve Replacement Co >EW

15.07.2024 г., 13:00 ч. UTC

Придобивния, сливания и поглъщания

Edwards Lifesciences To Acquire Innovalve >EW

4.06.2024 г., 17:26 ч. UTC

Придобивния, сливания и поглъщания

Edwards Lifesciences Deal A Clear Win For Becton Dickinson, Analysts Say -- Analysis

3.06.2024 г., 13:26 ч. UTC

Придобивния, сливания и поглъщания

Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal -- IBD

3.06.2024 г., 12:25 ч. UTC

Топ новини
Придобивния, сливания и поглъщания

Becton Dickinson to Acquire Edwards Lifesciences' Unit for $4.2 Billion in Cash -- Update

3.06.2024 г., 11:03 ч. UTC

Топ новини
Придобивния, сливания и поглъщания

Becton Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2B in Cash

3.06.2024 г., 10:40 ч. UTC

Придобивния, сливания и поглъщания

Edwards Lifesciences To Sell Its Critical Care Product Group For $4.2 Billion To Becton Dickinson -- MarketWatch

3.06.2024 г., 10:32 ч. UTC

Придобивния, сливания и поглъщания

Becton Dickinson: Acquired Business Has About 4,500 Employees >BDX EW

3.06.2024 г., 10:31 ч. UTC

Придобивния, сливания и поглъщания

Becton Dickinson: Acquired Business Generated More Than $900 Million Revenue in 2023 >BDX

3.06.2024 г., 10:31 ч. UTC

Придобивния, сливания и поглъщания

Becton Dickinson: Deal Expands Portfolio of Smart Connected Care Solutions >BDX EW

3.06.2024 г., 10:30 ч. UTC

Придобивния, сливания и поглъщания

Becton Dickinson to Buy Edwards Lifesciences Critical Care Product Group for $4.2 Billion >BDX EW

3.06.2024 г., 10:30 ч. UTC

Придобивния, сливания и поглъщания

BD To Acquire Edwards Lifesciences' Critical Care Product Group For $4.2 Billion To Expand Smart Connected Care Solutions And Become An Advanced Monitoring Technology Leader >BDX EW

26.04.2024 г., 20:10 ч. UTC

Печалби

This 'Critical' Business Helped Edwards Lifesciences Offset Its TAVR Miss -- IBD

Сравнение с други в отрасъла

Ценова промяна

Edwards Lifesciences Corp Прогноза

Ценова цел

By TipRanks

7.89% нагоре

12-месечна прогноза

Среден 77.54 USD  7.89%

Висок 90 USD

Нисък 60 USD

Според 19 анализатори от Wall Street, предложили 12-месечна ценова цел за Edwards Lifesciences Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

19 ratings

7

Купи

11

Задържане

1

Продай

Техническа оценка

By Trading Central

71.2 / 72.48Подкрепа & съпротива

Краткосрочен план

Strong Bullish Evidence

Средносрочен план

Bullish Evidence

Дългосрочен план

Weak Bullish Evidence

Настроение

By Acuity

55 / 386 Класиране в Здравеопазване

Настроения в новините

Много силни бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Edwards Lifesciences Corp

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.